7 October 2010

In the last issue of New Science we highlighted the innovative research by Dr. Vehid Salih and Dr. Jamie Harle into a human, in vitro model of cartilage for testing the healing properties of ultrasound.
Currently, Drs Salih and Harle are working on modifications to the ultrasound exposure rig to expand the range of acoustic outputs available. The best scaffold composition will be used in the `exposure´ work for the next stage of the project. This will enable exposure of pulsed ultrasound signals, rather than the continuous wave form used in the work so far.
During the next phase of the work, researchers aim to investigate the biological responses of hMSC (human mesenchymal stem cells) for both diagnostic and therapeutic ultrasound exposure parameters. The exposure rig will be modified further allowing ultrasound signals to be amplified so that varying intensities of ultrasound can be delivered to the hMSC-alginate constructs.
The model will then be used to look for ultrasound-induced effects which are intensity-, exposure time-, or pulsing regime-dependent.
As the use of donor grafts to solve orthopaedic problems is not ideal, producing natural tissues artificially, with the use of such a scaffold to guide regeneration, is a good alternative. The regeneration of bone tissue can be greatly improved by regular treatment with therapeutic ultrasound. Therefore, the current research has great potential to develop these methods to greatly benefit patients with cartilage injuries.
The presentation was well received at the European Society for Biomaterials´ Annual Congress in September 2009, promoting the use of HA(hydroxyapatite)/alginate as an animal-free scaffold for an in vitro model of cartilage. The European Society for Biomaterials publishes a monthly journal and holds annual conferences to encourage progress in the field of biomaterials.